A Feasibility Trial to Investigate the Safety and Between-group Effect Size of Stimulan-VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis of the Forefoot.
Condition: Diabetic Foot Osteomyelitis Interventions: Drug: Stimulan-VG; Drug: Systemic Antibiotics Sponsors: Biocomposites Ltd; Parexel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2022 Category: Research Source Type: clinical trials
